Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Vector-Borne Diseases: Trypanosomiasis April 1st, 2010 The Pathogen • Genus Trypanosoma • Two species of human health importance: – Trypanosoma brucei – Trypanosoma cruzi • The T. brucei complex (2 subspecies): – – – – Trypanosoma brucei rhodesiense Trypanosoma brucei gambiense Cannot tell them apart by morphology Cause distinct disease entities The Pathogen • Protozoan hemoflagellates – Single celled – flagella • Complex life cycle – Vector – Human – animals • Reservoirs: – Humans – Cattle The Pathogen Trypanosoma brucei ssp. in thin blood smears stained with Giemsa. Overview • Three types of trypanosomiasis – West African (sleeping sickness) – East African (sleeping sickness) – American (Chaga’s disease) • Differences – Geographic distribution – Vectors – Disease process West African Trypanosomiasis • Sleeping sickness • Trypanosoma brucei gambiense • Geographic distribution – Western and Central Africa – Vector distribution • Always fatal without treatment • Disease course over years – acute and chronic phases West African Trypanosomiasis • This form is ~95% of reported cases • 12,000-15,000 reported cases/year, WHO estimates 50-60,000 are really infected • Humans are the reservoir • Disease of rural areas; urban transmission is rare East African Trypanosomes • Trypanosoma brucei rhodesiense • Geographic distribution – East and Southeast Africa • Always fatal without treatment • Acute course compared to gambiense form • Cattle are additional reservoir Cases of African trypanosomiasis Geographic distribution Geographic distribution The vector • Tsetse fly • Glossina species • Takes a blood meal • trypomastigotes are the form transmitted to the host • Daytime feeder • Savannah and riverine flies Life Cycle: Trypanosomes Disease • Length of disease process differs between two • Sore may develop at site of initial inoculation – hemolymphatic stage – fever, lymphadenopathy, and pruritus. • meningoencephalitic stage – – – – Parasite crosses blood-brain barrier invasion of the central nervous system headaches, somnolence, abnormal behavior loss of consciousness and coma • more acute disease with T. b. rhodesiense than T. b. gambiense. Immunity • Humans do mount immune response • No residual immunity • cyclic fluctuation in the number of parasites in blood • Each new wave of parasite represents a different antigenic variant Diagnosis • Microscopic examination – – – – – chancre fluid lymph node aspirates Blood bone marrow cerebrospinal fluid (late stages of infection) • smear stained with Giemsa Treatment • Pentamidine isethionate – hemolymphatic stage of West African • suramin – hemolymphatic stage of East African • Melarsoprol – arsenical – late disease with central nervous system involvement – T.b. gambiense or T. b. rhodiense • Eflornithine – Expensive – not widely available – effective only for West African Control • Bite prevention – Difficult with daytime biters • Control vector habitats • Treat infected people – Screening methods are available • Bednets not useful Vector control • Control with insecticides – sequential aerosol spraying technique (SAT) – ground spraying – insecticide-treated targets or insecticidetreated animals • Traps • sterile insect technique (SIT). American trypanosomiasis • Chaga’s Disease • Trypanosoma cruzi • Geographic distribution – southern United States to southern Argentina • A disease of poor, rural areas of Mexico, Central America, and South America • Humans and animals are reservoir Geographic distribution Vector • triatomine bugs (kissing bugs) • Triatoma, Rhodinius, and Panstrongylus • Takes a blood meal • Releases trypomastigotes in its feces near the site of the bite • Enter host through the wound Life Cycle: Chaga’s disease Disease • Acute phase – usually asymptomatic – fever, anorexia, lymphadenopathy, myocarditis – Lesion (chagoma) at site of inoculation • Resolve over a period of a few weeks or months into an asymptomatic chronic form – 20-30% of cases • Years or decades after initial infection: – cardiomyopathy – GI complications – can be fatal Diagnosis • Microscopic examination – – fresh anticoagulated blood thin and thick blood smears stained with Giemsa • Isolation of the agent: – – – inoculation in culture with specialized media inoculation into mice xenodiagnosis Treatment • Benznidazole • nifurtimox • Treatment is most effective during the acute phase • Drugs are fairly toxic • IND protocol from the CDC Control • Vector control • Poorly constructed houses and houses with thatched roofs are at risk • Treatment of houses with insecticides • Get rid of places in dwellings where vector and reservoir animals can live and breed • Bednets